| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
mutS homolog 6 | 0.462 | 0.731 | 3.7E-05 |
|
disease | 0.600 | strong | 0.974 | 12 | 32 | 1988 | 2020 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
disease | 0.800 | strong | 0.973 | 14 | 16 | 1993 | 2020 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.800 | strong | 0.972 | 7 | 16 | 1990 | 2020 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
disease | 0.800 | strong | 0.971 | 5 | 11 | 1993 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.700 | None | 0.985 | 2 | 11 | 2002 | 2020 | ||||||||
|
mutY DNA glycosylase | 0.521 | 0.769 | 1.3E-18 |
|
disease | 0.500 | strong | 0.947 | 0 | 9 | 2002 | 2019 | ||||||||
|
SMAD family member 7 | 0.470 | 0.769 | 0.55 |
|
disease | 0.500 | None | 0.984 | 1 | 8 | 2001 | 2019 | ||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
disease | 0.660 | None | 1.000 | 0 | 8 | 2000 | 2018 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.700 | None | 0.947 | 8 | 7 | 1989 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.976 | 8 | 5 | 2002 | 2020 | ||||||||
|
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF | 0.736 | 0.538 | 1.9E-164 |
|
disease | 0.310 | None | 1.000 | 0 | 5 | 2012 | 2012 | ||||||||
|
serine/threonine kinase 11 | 0.435 | 0.808 | 0.99 |
|
disease | 0.600 | strong | 1.000 | 0 | 5 | 1998 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.600 | None | 0.963 | 3 | 4 | 1990 | 2020 | ||||||||
|
gremlin 1, DAN family BMP antagonist | 0.508 | 0.808 | 0.47 |
|
disease | 0.500 | None | 0.957 | 2 | 4 | 2003 | 2019 | ||||||||
|
cyclin D2 | 0.477 | 0.808 | 0.99 |
|
disease | 0.450 | None | 1.000 | 1 | 4 | 2010 | 2019 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
disease | 0.500 | None | 0.938 | 1 | 4 | 2000 | 2019 | ||||||||
|
vesicle transport through interaction with t-SNAREs 1A | 0.674 | 0.154 | 5.4E-04 |
|
disease | 0.420 | None | 1.000 | 1 | 4 | 2011 | 2019 | ||||||||
|
fatty acid desaturase 2 | 0.575 | 0.692 | 1.00 |
|
disease | 0.400 | None | 1.000 | 1 | 4 | 2014 | 2019 | ||||||||
|
nucleoredoxin | 0.584 | 0.577 | 1.00 |
|
disease | 0.400 | None | 1.000 | 1 | 4 | 2014 | 2019 | ||||||||
|
rhophilin Rho GTPase binding protein 2 | 0.711 | 0.192 | 1.1E-07 |
|
disease | 0.440 | None | 1.000 | 1 | 4 | 2008 | 2019 | ||||||||
|
laminin subunit gamma 1 | 0.628 | 0.654 | 1.00 |
|
disease | 0.410 | None | 1.000 | 0 | 4 | 2013 | 2019 | ||||||||
|
folliculin | 0.537 | 0.885 | 0.79 |
|
disease | 0.400 | None | 0 | 4 | |||||||||||
|
BUB1 mitotic checkpoint serine/threonine kinase | 0.528 | 0.731 | 4.9E-09 |
|
disease | 0.700 | None | 1.000 | 0 | 4 | 2000 | 2018 | ||||||||
|
MCC regulator of WNT signaling pathway | 0.568 | 0.731 | 4.7E-16 |
|
disease | 0.500 | None | 0.929 | 0 | 4 | 1991 | 2018 | ||||||||
|
E1A binding protein p300 | 0.459 | 0.846 | 1.00 |
|
disease | 0.640 | None | 1.000 | 0 | 4 | 1996 | 2017 |